HK Stock Market Move | XINGDA INT'L (01899) falls over 9%, with first-half profit expected to drop by 60% to 75% due to foreign exchange losses and other factors.

10:55 18/08/2026

Singda International (01899) fell over 9%. As of the time of publication, it dropped by 9.05%, trading at HKD 1.055, with a transaction volume of HKD 2.424 million.

XINGDA INT'L (01899) dropped over 9%. As of the time of writing, it has fallen by 9.05%, trading at HKD 1.055, with a trading volume of HKD 2.424 million. In news, XINGDA INT'L issued a profit warning last night, expecting the profit attributable to equity holders for the first half of this year to decline by 60% to 75% year-on-year, with the profit attributable to equity holders for the same period in 2025 being approximately HKD 199 million. This is mainly due to the company's shift from net exchange gains to acknowledging net exchange losses under "other income and losses," primarily caused by exchange rate fluctuations; the decline in bank interest income under "other income" is mainly due to a year-on-year decrease in average fixed deposits and a reduction in bank deposit interest rates.

HK Stock Market Move | SKB BIO (06990) rose over 4% in the morning, as the commercialization of its product matrix scales up. The product sales for the first half of the year doubled compared to the same period last year.

Jiangsu Nhwa Pharmaceutical (002262.SZ): Class 1 innovative drug NH302 injection has been approved to conduct clinical trials.

HK Stock Market Move | TENGY ENV (01527) surged over 50%, expecting a nearly seven-fold year-on-year increase in net profit for the first half of the year, with revenue confirmed upon project completion.

Jiangsu Nhwa Pharmaceutical (002262.SZ): Class 1 innovative drug NH302 injection has been approved to conduct clinical trials.